MediWound Ltd. (MDWD)
NASDAQ: MDWD · Real-Time Price · USD
16.49
-0.71 (-4.13%)
Dec 20, 2024, 4:00 PM EST - Market closed
MediWound Employees
MediWound had 100 employees as of December 31, 2023. The number of employees increased by 17 or 20.48% compared to the previous year.
Employees
100
Change (1Y)
17
Growth (1Y)
20.48%
Revenue / Employee
$197,200
Profits / Employee
-$280,590
Market Cap
177.93M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Organigram Holdings | 984 |
Fate Therapeutics | 181 |
Molecular Partners AG | 168 |
Quantum-Si incorporated | 159 |
Stereotaxis | 122 |
Myomo | 106 |
Orchestra BioMed Holdings | 56 |
Cybin | 50 |
MDWD News
- 25 days ago - MediWound Ltd. (MDWD) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 25 days ago - MediWound Reports Third Quarter 2024 Financial Results and Provides Company Update - GlobeNewsWire
- 7 weeks ago - MediWound Is A Healthy Investment - Seeking Alpha
- 2 months ago - MediWound Announces Phase II Head-to-Head Study Evaluating EscharEx® vs. Collagenase in Patients with Venous Leg Ulcers - GlobeNewsWire
- 4 months ago - MediWound Announces U.S. Food and Drug Administration Approval of NexoBrid® for the Treatment of Pediatric Patients with Severe Thermal Burns - GlobeNewsWire
- 4 months ago - MediWound Ltd. (MDWD) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - MediWound Reports Second Quarter 2024 Financial Results and Provides Company Update - GlobeNewsWire
- 4 months ago - MediWound Announces Positive Results from the U.S. NexoBrid® Expanded Access Protocol (NEXT) - GlobeNewsWire